Page last updated: 2024-10-30

meclofenamic acid and Carcinoma, Small Cell Lung

meclofenamic acid has been researched along with Carcinoma, Small Cell Lung in 1 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yanar, S1
Kasap, M1
Kanli, A1
Akpinar, G1
Sarihan, M1

Other Studies

1 other study available for meclofenamic acid and Carcinoma, Small Cell Lung

ArticleYear
Proteomics analysis of meclofenamic acid-treated small cell lung carcinoma cells revealed changes in cellular energy metabolism for cancer cell survival.
    Journal of biochemical and molecular toxicology, 2023, Volume: 37, Issue:4

    Topics: Cell Line, Tumor; Cell Survival; Chromatography, Liquid; Glycolysis; Humans; Lung Neoplasms; Meclofe

2023